Form 13-F position report

VYNE THERAPEUTICS INC COM PAR$

Reported by FRED ALGER MANAGEMENT LLC

Company profile Manager portfolio Source filing
VYNE CUSIP 92941V308 Manager CIK 0000003520
Latest reported change

Reported 0 shares, down 60,055 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q1 2024
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 2 Through Q1 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Manager history

Quarterly position history

How this manager's reported quarter-end position changed over time.

2 quarters
Quarter Activity Shares Change % of reported 13F Reported value Filed
Q1 2024 Reduced 0 -60,055 (-100.0%) 0 $0 2024-05-15
Q4 2023 New 60,055 +60,055 (0.0%) < 0.01% $139,928 2024-02-14
Institutional context

Who else reported the position

37 managers reported VYNE THERAPEUTICS INC COM PAR$ for Q1 2024.

Manager Activity Shares Change % of reported 13F Reported value Tenure
Cormorant Asset Management LP Unchanged 1,394,336 0 0.19% $4,280,612 2 qtrs
CITADEL ADVISORS LLC Unchanged 1,181,088 0 < 0.01% $3,625,940 2 qtrs
EVENTIDE ASSET MANAGEMENT LLC Unchanged 1,394,336 0 0.05% $3,130,284 2 qtrs
Parkman Healthcare Partners LLC Unchanged 696,470 0 0.26% $2,138,163 2 qtrs
DSC Advisors L P Unchanged 696,465 0 3.42% $2,138,148 5 qtrs
Palo Alto Investors LP Unchanged 445,434 0 0.15% $1,367,482 2 qtrs
AlphaCentric Advisors LLC Reduced 445,000 -223,151 0.82% $1,366,150 2 qtrs
Exome Asset Management LLC Added 415,434 +297,334 1.09% $1,275,382 2 qtrs
Schonfeld Strategic Advisors LLC New 219,800 +219,800 < 0.01% $674,786 1 qtr
ROYAL BANK OF CANADA Added 175,372 +174,107 < 0.01% $538,000 5 qtrs
A free account expands this comparison to 25 managers. Create free account
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2024
Filed
May 15, 2024
Filing type
13F-HR
Position type
Common

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.